FMR1 and fragile X syndrome: In FXS male patients and in CVS samples from full mutation fetuses, all FMR1 methylation sensitive probes showed a peak ratio value > 0.64 (Figure 1E,F; Table 2), indicating the presence of an aberrant methylation of the FMR1 promoter, concordant with the diagnosis of FXS previously assessed by SB analysis.